Navigation Links
Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
Date:12/8/2009

SAN DIEGO, Dec. 8 /PRNewswire/ -- Biomatrica, the leader in room temperature biological sample stabilization, today announced the release of DNAgard(TM), the first room temperature-based liquid formulation for stabilization and storage of tissues and cells. The new DNAgard product adds to Biomatrica's portfolio of solutions for room-temperature storage, archiving, stabilization and transportation of biological samples. Utilizing Biomatrica's SampleMatrix® technology platform, DNAgard significantly simplifies transport and storage of tissues and cells at room temperature by preserving the quality and the quantity of genomic DNA in these biological samples.

With the release of DNAgard, tissues and cells can now be conveniently shipped and/or stored in a liquid format for at least 60 days at ambient room temperature without losing sample quality. An optional dry-down format permits room-temperature stabilization of DNA in tissues and cells for at least one year.

"This is an optimal biostability solution for sample collection, storage and shipping, particularly for field researchers, where freezers and dry ice are a challenge," said Laurent Coulon, Ph.D., product manager at Biomatrica. "Researchers can now easily, safely and cost effectively transport their field collections of biological samples to the lab without fear of sample quality degradation. Room temperature bio-sample storage is also very economical and an eco-friendly solution."

Tissues are currently transported in dry ice and stored at minus 80 degrees C until further processing. These cold shipping and storage methods are expensive, non-environmentally friendly, take space in the freezer and in shipment. The shipping of a few tissue samples on dry-ice requires a 10 pound package size and costs an average of $150 when shipped nationally. Using the innovative DNAgard solution, these samples can be shipped at ambient temperature in an envelope for an average cost of only $10.

SampleMatrix is based on extremophile biology in which organisms are able to survive long term in a state of anhydrobiosis (life without water) and later be revived by rehydration. Extremophiles such as tardigrades, also known as water bears are able to protect their DNA, RNA, proteins, membranes and cells in a dried state for extended periods of time. Biomatrica's technology mimics the natural molecular mechanisms used by these organisms.

About Biomatrica® Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing, shipping and assaying biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types such as proteins are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this technology platform (DNAstable® and DNAgard(TM) for DNA, RNAstable® for RNA and CloneStable® for bacterial DNA), visit: http://www.biomatrica.com/.


Contact:
Heidi Chokeir, Ph.D.
Russo Partners
(619) 528-2217
heidi.chokeir@russopartnersllc.com

SOURCE Biomatrica Inc.


'/>"/>
SOURCE Biomatrica Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):